Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease
Abstract
Introduction Unexplained chest pain is potentially attributable to gastro-oesophageal reflux disease (GORD) or oesophageal motility disorders. Reflux chest pain may occur without heartburn. We explored the response of unexplained chest pain to proton pump inhibitor (PPI) therapy in randomised clinical trials (RCTs), differentiating patients with and without objective evidence of GORD. Methods PubMed and Embase were systematically searched for RCTs that reported chest pain response to PPIs in patients who had had pH-monitoring and/or endoscopy to differentiate GORD-positive from GORD-negative subpopulations. Heterogeneity among studies was assessed using the Cochran Q and I2 statistics, and a fixed effect model was applied. Possible publication bias was assessed by Egger's test. Results Six RCTs met the inclusion criteria. All used 24 h pH monitoring and/or endoscopy to define GORD-positive patients and improvement in chest pain to define response (five used ≥50%; one used ≥20%). The therapeutic gain of >50% improvement with PPIs relative to placebo was 56–85% in GORD-positive and 0–17% in GORD-negative patients. The RR of >50% improvement in chest pain with PPI versus placebo was 4.3 (95% CI 2.8 to 6.7; pConclusions Unexplained chest pain in patients with endoscopic or pH-monitoring evidence of GORD tends to improve, but not resolve, with PPI therapy, whereas GORD-negative patients have little or no response. Heartburn was a poor predictor of whether patients with chest pain were GORD-positive or GORD-negative by objective testing.Keywords
This publication has 28 references indexed in Scilit:
- Lysophosphatidic Acid Stimulates the Intestinal Brush Border Na+/H+ Exchanger 3 and Fluid Absorption via LPA5 and NHERF2Gastroenterology, 2010
- Comparison of one‐week and two‐week empirical trial with a high‐dose rabeprazole in non‐cardiac chest pain patientsJournal of Gastroenterology and Hepatology, 2009
- Non‐cardiac chest pain: Prevalence of reflux disease and response to acid suppression in an Asian populationJournal of Gastroenterology and Hepatology, 2009
- Effect of Antisecretory Therapy on Atypical Symptoms in Gastroesophageal Reflux DiseaseDigestive Diseases and Sciences, 2007
- THE PROTON PUMP INHIBITOR TEST IN NON-CARDIAC CHEST PAIN: USE IT OR LOSE IT?Evidence-Based Gastroenterology, 2005
- The effect of a therapeutic trial of high‐dose rabeprazole on symptom response of patients with non‐cardiac chest pain: a randomized, double‐blind, placebo‐controlled, crossover trialAlimentary Pharmacology & Therapeutics, 2005
- The effect of an empirical trial of high‐dose lansoprazole on symptom response of patients with non‐cardiac chest pain – a randomized, double‐blind, placebo‐controlled, crossover trialAlimentary Pharmacology & Therapeutics, 2004
- The psychological aspects of noncardiac chest painGastroenterology Clinics of North America, 2004
- Short Course of OmeprazoleJournal of Clinical Gastroenterology, 2002
- Psychiatric Illness and Contraction Abnormalities of the EsophagusNew England Journal of Medicine, 1983